| Product Code: ETC9967628 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States saw a significant increase in hemostats import shipments in 2024, with top exporting countries being China, Mexico, Finland, Japan, and South Korea. The market concentration, as measured by HHI, decreased from moderate to low in 2024, indicating a more diversified import market. The impressive compound annual growth rate (CAGR) of 11.94% from 2020 to 2024 highlights the growing demand for hemostats in the US. Moreover, the strong growth rate of 17.67% from 2023 to 2024 suggests a promising outlook for the hemostats import market in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Hemostats Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Hemostats Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Hemostats Market - Industry Life Cycle |
3.4 United States (US) Hemostats Market - Porter's Five Forces |
3.5 United States (US) Hemostats Market Revenues & Volume Share, By Product type, 2021 & 2031F |
3.6 United States (US) Hemostats Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.7 United States (US) Hemostats Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 United States (US) Hemostats Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Hemostats Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgical procedures in the United States |
4.2.2 Growing prevalence of chronic diseases leading to a higher demand for hemostats |
4.2.3 Technological advancements in hemostatic products leading to improved efficiency and effectiveness |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of hemostatic products |
4.3.2 High cost associated with advanced hemostats impacting adoption rates |
4.3.3 Competition from alternative products such as sutures and sealants |
5 United States (US) Hemostats Market Trends |
6 United States (US) Hemostats Market, By Types |
6.1 United States (US) Hemostats Market, By Product type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Hemostats Market Revenues & Volume, By Product type, 2021- 2031F |
6.1.3 United States (US) Hemostats Market Revenues & Volume, By Combination, 2021- 2031F |
6.1.4 United States (US) Hemostats Market Revenues & Volume, By Oxidized regenerated cellulose based, 2021- 2031F |
6.1.5 United States (US) Hemostats Market Revenues & Volume, By Gelatine based, 2021- 2031F |
6.1.6 United States (US) Hemostats Market Revenues & Volume, By Collagen based haemostat, 2021- 2031F |
6.2 United States (US) Hemostats Market, By Formulation |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Hemostats Market Revenues & Volume, By Matrix and gel hemostats, 2021- 2031F |
6.2.3 United States (US) Hemostats Market Revenues & Volume, By Sheet and pad hemostats, 2021- 2031F |
6.2.4 United States (US) Hemostats Market Revenues & Volume, By Sponge hemostats, 2021- 2031F |
6.2.5 United States (US) Hemostats Market Revenues & Volume, By Powder hemostats, 2021- 2031F |
6.3 United States (US) Hemostats Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Hemostats Market Revenues & Volume, By Closure, 2021- 2031F |
6.3.3 United States (US) Hemostats Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4 United States (US) Hemostats Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Hemostats Market Revenues & Volume, By Ambulatory centers, 2021- 2031F |
6.4.3 United States (US) Hemostats Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 United States (US) Hemostats Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.5 United States (US) Hemostats Market Revenues & Volume, By Community healthcare, 2021- 2031F |
6.4.6 United States (US) Hemostats Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Hemostats Market Import-Export Trade Statistics |
7.1 United States (US) Hemostats Market Export to Major Countries |
7.2 United States (US) Hemostats Market Imports from Major Countries |
8 United States (US) Hemostats Market Key Performance Indicators |
8.1 Adoption rate of advanced hemostatic products in surgical procedures |
8.2 Number of patents filed for innovative hemostatic technologies |
8.3 Rate of complications related to hemostat usage in surgeries |
8.4 Average length of hospital stay post-surgery where hemostats are used |
8.5 Investment in research and development for hemostatic products |
9 United States (US) Hemostats Market - Opportunity Assessment |
9.1 United States (US) Hemostats Market Opportunity Assessment, By Product type, 2021 & 2031F |
9.2 United States (US) Hemostats Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.3 United States (US) Hemostats Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 United States (US) Hemostats Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Hemostats Market - Competitive Landscape |
10.1 United States (US) Hemostats Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Hemostats Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |